These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34669010)

  • 1. Physiologically based kinetic modelling predicts the in vivo relative potency of riddelliine N-oxide compared to riddelliine in rat to be dose dependent.
    Widjaja F; Wesseling S; Rietjens IMCM
    Arch Toxicol; 2022 Jan; 96(1):135-151. PubMed ID: 34669010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologically based kinetic modeling of senecionine N-oxide in rats as a new approach methodology to define the effects of dose and endpoint used on relative potency values of pyrrolizidine alkaloid N-oxides.
    Widjaja F; Zheng L; Wesseling S; Rietjens IMCM
    Front Pharmacol; 2023; 14():1125146. PubMed ID: 36937884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an in vitro-in silico testing strategy to predict inter-species and inter-ethnic human differences in liver toxicity of the pyrrolizidine alkaloids lasiocarpine and riddelliine.
    Ning J; Chen L; Strikwold M; Louisse J; Wesseling S; Rietjens IMCM
    Arch Toxicol; 2019 Mar; 93(3):801-818. PubMed ID: 30661089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro-in silico study on the influence of dose, fraction bioactivated and endpoint used on the relative potency value of pyrrolizidine alkaloid N-oxides compared to parent pyrrolizidine alkaloids.
    Alhejji Y; Widjaja F; Tian S; Hoekstra T; Wesseling S; Rietjens IMCM
    Curr Res Toxicol; 2024; 6():100160. PubMed ID: 38469320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of in vivo genotoxicity of lasiocarpine and riddelliine in rat liver using a combined in vitro-physiologically based kinetic modelling-facilitated reverse dosimetry approach.
    Chen L; Peijnenburg A; de Haan L; Rietjens IMCM
    Arch Toxicol; 2019 Aug; 93(8):2385-2395. PubMed ID: 31289892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of physiologically based kinetic modelling-facilitated reverse dosimetry to convert in vitro cytotoxicity data to predicted in vivo liver toxicity of lasiocarpine and riddelliine in rat.
    Chen L; Ning J; Louisse J; Wesseling S; Rietjens IMCM
    Food Chem Toxicol; 2018 Jun; 116(Pt B):216-226. PubMed ID: 29634986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physiologically-Based Kinetic Modeling Predicts Similar In Vivo Relative Potency of Senecionine N-Oxide for Rat and Human at Realistic Low Exposure Levels.
    Widjaja F; Alhejji Y; Yangchen J; Wesseling S; Rietjens IMCM
    Mol Nutr Food Res; 2023 Feb; 67(4):e2200293. PubMed ID: 36478522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine.
    Chou MW; Wang YP; Yan J; Yang YC; Beger RD; Williams LD; Doerge DR; Fu PP
    Toxicol Lett; 2003 Dec; 145(3):239-47. PubMed ID: 14580895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Kinetics as Key Determinant in Toxicity of Pyrrolizidine Alkaloids and Their N-Oxides.
    Widjaja F; Alhejji Y; Rietjens IMCM
    Planta Med; 2022 Feb; 88(2):130-143. PubMed ID: 34741297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach.
    Suparmi S; Wesseling S; Rietjens IMCM
    Arch Toxicol; 2020 Sep; 94(9):3281-3295. PubMed ID: 32518961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives.
    Ning J; Chen L; Rietjens IMCM
    Food Chem Toxicol; 2019 Sep; 131():110572. PubMed ID: 31185270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides - Mechanism and its potential toxic impact.
    Yang M; Ma J; Ruan J; Zhang C; Ye Y; Pi-Cheng Fu P; Lin G
    J Ethnopharmacol; 2020 Mar; 249():112421. PubMed ID: 31759111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.
    Yang M; Ma J; Ruan J; Ye Y; Fu PP; Lin G
    Arch Toxicol; 2019 Aug; 93(8):2197-2209. PubMed ID: 31222523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2003 May; (508):1-280. PubMed ID: 12844193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of enzyme-linked immunosorbent assays for the hepatotoxic alkaloids riddelliine and riddelliine N-oxide.
    Lee ST; Schoch TK; Stegelmeier BL; Gardner DR; Than KA; Molyneux RJ
    J Agric Food Chem; 2001 Aug; 49(8):4144-51. PubMed ID: 11513723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression changes induced by the tumorigenic pyrrolizidine alkaloid riddelliine in liver of Big Blue rats.
    Mei N; Guo L; Liu R; Fuscoe JC; Chen T
    BMC Bioinformatics; 2007 Nov; 8 Suppl 7(Suppl 7):S4. PubMed ID: 18047727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver.
    Chen T; Li Z; Yan J; Yang X; Salminen W
    Mutagenesis; 2012 Jan; 27(1):59-66. PubMed ID: 21976715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine.
    Xia Q; Chou MW; Kadlubar FF; Chan PC; Fu PP
    Chem Res Toxicol; 2003 Jan; 16(1):66-73. PubMed ID: 12693032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic relative potency of a series of pyrrolizidine alkaloids characterized by rate and extent of metabolism.
    Lester C; Troutman J; Obringer C; Wehmeyer K; Stoffolano P; Karb M; Xu Y; Roe A; Carr G; Blackburn K; Mahony C
    Food Chem Toxicol; 2019 Sep; 131():110523. PubMed ID: 31129256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.